Position in LLY
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$138,026,817
+$34,701,696 QoQ
Shares Held
115,077
+2.4% QoQ
Ownership
0.012%
of shares outstanding
% of Portfolio
4.02%
of 13F equity value
Holder Rank
#328
of 4,605 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 15%
Shared 85%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Silvant Capital Management LLC holds $144,195,613 across 8 Drug Manufacturers - General names. LLY ranks #1 (95.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
115,077 | $138,026,817 | |
| 2 | MRK |
Merck & Co., Inc.
|
25,811 | $3,316,713 | |
| 3 | ABBV |
AbbVie Inc.
|
4,037 | $1,015,870 | |
| 4 | JNJ |
Johnson & Johnson
|
2,471 | $627,559 | |
| 5 | AMGN |
Amgen Inc
|
1,245 | $450,839 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
5,887 | $339,208 | |
| 7 | PFE |
Pfizer Inc
|
9,981 | $240,342 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
1,411 | $178,265 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $138,026,817 | 115,077 | Shares | Other | 2026-08-11 | |
| 2026-03-31 | $103,325,121 | 112,338 | Shares | Other | 2026-05-14 | |
| 2025-12-31 | $114,319,095 | 106,375 | Shares | Other | 2026-02-13 | |
| 2025-09-30 | $82,144,580 | 107,660 | Shares | Other | 2025-11-13 | |
| 2025-06-30 | $73,484,733 | 94,268 | Shares | Other | 2025-08-13 | |
| 2025-03-31 | $77,360,511 | 93,667 | Shares | Other | 2025-05-14 | |
| 2024-12-31 | $72,022,196 | 93,293 | Shares | Other | 2025-02-13 | |
| 2024-09-30 | $82,804,381 | 93,465 | Shares | Other | 2024-10-29 | |
| 2024-06-30 | $84,718,216 | 93,572 | Shares | Other | 2024-07-25 | |
| 2024-03-31 | $76,681,960 | 98,568 | Shares | Other | 2024-04-30 | |
| 2023-12-31 | $61,541,195 | 105,574 | Shares | Other | 2024-01-25 | |
| 2023-09-30 | $58,185,143 | 108,326 | Shares | Other | 2023-10-24 | |
| 2023-06-30 | $59,674,890 | 127,244 | Shares | Other | 2023-07-25 | |
| 2023-03-31 | $42,508,183 | 123,779 | Shares | Other | 2023-04-26 | |
| 2022-12-31 | $46,044,987 | 125,861 | Shares | Other | 2023-01-23 | |
| 2022-09-30 | $47,210,069 | 146,003 | Shares | Other | 2022-11-09 | |
| 2022-06-30 | $7,016,336 | 21,640 | Shares | Other | 2022-08-03 | |
| 2022-03-31 | $6,187,882 | 21,608 | Shares | Other | 2022-05-05 | |
| 2021-12-31 | $6,038,997 | 21,863 | Shares | Other | 2022-02-07 | |
| 2021-09-30 | $5,270,481 | 22,811 | Shares | Other | 2021-11-08 | |
| 2021-06-30 | $6,199,105 | 27,009 | Shares | Other | 2021-08-03 | |
| 2021-03-31 | $5,128,768 | 27,453 | Shares | Other | 2021-05-11 | |
| 2020-12-31 | $3,445,011 | 20,404 | Shares | Other | 2021-02-05 | |
| 2020-09-30 | $234,759 | 1,586 | Shares | Sole | 2020-11-09 | |
| 2020-06-30 | $260,389 | 1,586 | Shares | Sole | 2020-08-11 | |
| 2020-03-31 | $220,009 | 1,586 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||